The BioVenture eLab, part of BioPharma Alliances & Research Collaborations,
is a new program at Weill Cornell Medicine.
is a new program at Weill Cornell Medicine.
Our mission to foster an entrepreneurial ecosystem for researchers, clinicians and staff at Weill Cornell Medicine.
— Lewis C. Cantley, Ph.D. Co-Founder of Agios Pharmaceuticals (NASDAQ: AGIO) and Petra Pharma Corp., Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College/Ronald P. Stanton Clinical Cancer Program at NewYork-Presbyterian, Professor of Cancer Biology in Medicine, Addresses the 2017 Startup Symposium audience at Weill Cornell Medicine.
— Winning teams from first Biomedical Business Plan Challenge show off their trophies.
We provide access to resources, training and mentorship in biomedical entrepreneurship.
Our goal is to position members of the WCM community for success and to build the next generation of leaders in life science industries and new ventures.
— Nick Bramain, Tri-I PhD Candidate in Computational Biology & Medicine, from Nicholas Schiff, MD, lab demonstrates his EEG algorithm protoype to entrepreneurs and investors.